Search results
Vail Resorts Shares Tumble on Lowered Profit Outlook By Investing.com
Investing.com· 22 hours agoVail Resorts, Inc. (NYSE:MTN) faced a chilly investor reception as shares fell 6.6% following the...
Nio Provides A Glimmer Of Hope With Margin Improvements And Optimistic EV Delivery Outlook
Benzinga via Yahoo Finance· 3 hours agoBut Nio managed to lift the spirits with a more optimistic second quarter outlook. Moreover, it...
European smartphone market sees growth for the first time in years
Android Headlines· 3 hours agoContrary to the global trend, smartphone sales in the US declined. The region saw a first YoY...
2 of the Best Artificial Intelligence (AI) Stocks to Buy in 2024
Motley Fool via Yahoo Finance· 1 day agoSome analysts estimate that Nvidia controls as much as 90% of the AI chip market. To underline this,...
Earnings call: Samsara posts strong Q1 results, raises FY '25 guidance By Investing.com
Investing.com· 7 hours agoSamsara Inc. (NYSE:IOT), a leader in Internet of Things (IoT) solutions, has announced robust...
Europe Roundup: Sterling set for fourth weekly rally ahead of US payrolls, European shares falls,...
EconoTimes· 6 hours agoMarket Roundup German Apr Exports (MoM) 1.6%,1.1% forecast,0.9% previous German Apr Imports (MoM)...
In data: Chinese market showed steady performance with sustained demand in April
Just Auto via Yahoo Finance· 1 day agoDomestic Light Vehicle (LV) sales, excluding exports, surged to 1.8 million units, marking a 3.5%...
Strategic Education's (NASDAQ:STRA) three-year earnings growth trails the 19% YoY shareholder...
Simply Wall St. via Yahoo Finance· 1 day agoBy buying an index fund, investors can approximate the average market return. But many of us dare to...
Samsara Shares Drop 5% Despite Q1 Earnings Beat, Raised Outlook By Investing.com
Investing.com· 22 hours agoSamsara Inc. (NYSE:IOT), a leader in connected operations cloud technology, announced its...
Scilex gains FDA approval for liquid version of colchine for gout flares
Seeking Alpha· 21 hours agoThe U.S. FDA approves Scilex Holdings' Gloperba, a liquid form of colchicine for gout flares. Read...